Crewe Advisors LLC Incyte Corp Transaction History
Crewe Advisors LLC
- $695 Million
- Q1 2025
Shares
1 transactions
Others Institutions Holding INCY
# of Institutions
697Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.07 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.44 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$675 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...